BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
CAPS Rating:
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
RSS Headlines
Fool UK
Recs
Tempted to say "It's got nowhere to go but up". But I think they're just going to burn through cash like a flamethrower attached to an apache helicopter piloted by Ben Bernanke.